Skip to main content
. 2019 Nov 6;5(2):260–268. doi: 10.1016/j.adro.2019.10.006

Table 1.

Patient characteristics

Patient No. of metastatic sites Replanned site Prescription dose PTV expansion (mm) PTV volume (mL)
1 4 Left 5th rib 9 Gy × 3 5 14.4
2 3 Left external iliac node 7.25 Gy × 5 4 24.2
3 4 Left sacroiliac joint 9 Gy × 3 3 19.4
4 1 External iliac node 8 Gy × 5 4 14.2
5 1 Right iliac node 9 Gy × 5 5 9.2
6 2 Left iliac node 9.5 Gy × 3 4 13.3
7 3 Presacral node 7 Gy × 5 5 15.3
8 6 Right iliac node 8 Gy × 5 5 3.2
9 2 Subcarinal node 6.4 Gy × 5 6 21.2
10 2 RP node 9 Gy × 5 5 15.4
11 1 Presacral node 7.25 Gy × 5 5 3.7
12 1 L1 vertebral body 12 Gy × 4 4 6.6
13 1 Left common iliac node 7.25 Gy × 5 6 5.8
14 2 Left internal iliac node 11 Gy × 3 5 8.0
15 1 Sacrum 11 Gy × 3 4 5.3
- Median (range) - - Median (range) Mean (SD)
2 (1-6) 5 (3-6) 11.9 (6.6)

Abbreviations: PTV = planning target volume; RP = retroperitoneal; SD = standard deviation.